Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
NOT YET RECRUITING
NCT07739147
EARLY_PHASE1

Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial

Sponsor: Kimberly Meathrel

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer: Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue light enhanced, or traditional PRP result in other improved hair metrics. Participants will consent to a PRP treatment but will be blinded to the type. They will then be asked to return for Tricholab analysis at set post-operative timepoints to record changes in hair metrics (Baseline, 1 month, 3 months, 6 months, 9 months, 12 months).

Official title: Photobiomodulated Platelet-Rich Plasma for Androgenetic Alopecia: A Randomized Controlled Trial Comparing Standard PRP vs Red-Light Enhanced vs Blue-Light Enhanced PRP Using the MetaCell Technologies System

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-12-30

Completion Date

2027-12-30

Last Updated

2026-07-31

Healthy Volunteers

No

Conditions

Androgenetic Alopecia

Interventions

DRUG

Platelet-Rich Plasma (PRP) Injections

Autologous platelet-rich plasma prepared from the participant's own peripherally drawn. Blood is processed via centrifugation to concentrate platelets and associated growth factors, then injected into the scalp across the area of hair thinning. Administered at each treatment visit per the study treatment schedule.

DEVICE

Red-light photobiomodulation with cooling

Standard Intervention 1 with PRP undergoing additional Stimulus 1: 620 nm, 1 J/cm², 10 minutes; Stimulus 2: 4°C cooling, 15 minutes via MetaCell Technologies System.

DEVICE

Blue-light photobiomodulation

Standard Intervention 1 with PRP undergoing additional Stimulus 1: 467 nm, 1 J/cm², 10 minutes; Stimulus 2: 37°C, 10 minutes using MetaCell Technologies System.